Insights on Discovery

  1. Structural Characterization Of RNA And Detection Of RNA-Ligand Binding 1/13/2025

    Delve into the intricacies of riboswitch behavior and ligand interactions and gain valuable insights into gene regulation and potential therapeutic targets.

  2. Assigning IR Absorption Bands For RNA Building Blocks Using Microfluidic Modulation Spectroscopy 1/13/2025

    Explore the power of MMS in identifying RNA base signatures. This study analyzes vibrational modes of A, G, C, and U, revealing insights into electronic environments and molecular interactions.

  3. Guidelines And Strategies For The Development, Qualification Of Potency Assay 1/7/2025

    Explore key strategies and guidelines to advance the development and qualification of robust potency assays for gene therapy products.

  4. A Flow Cytometry Toolkit To Measure Expression Of Metabolic Proteins 1/6/2025

    Learn about a method that utilizes monoclonal antibodies and flow cytometry to analyze the metabolic state of individual immune cells, advancing immune research and immunotherapy.

  5. Overview Of Parkinson's Disease: Global Clinical Trials Landscape 12/27/2024

    Parkinson's disease affects over 8.5 million globally. Explore how advances in gene therapy, Deep Brain Stimulation, and innovative drugs are transforming treatment and improving patient outcomes.

  6. Overview Of COVID-19: Global Clinical Trial Landscape 12/27/2024

    Explore how COVID-19 has led to significant global morbidity and mortality. Advances in vaccines, therapies, and clinical trials are enhancing disease management and outcomes.

  7. Transcriptome Profiling Of Cerebellar Organoids Grown In Dynamic Conditions 12/19/2024

    Learn about a method for generating human iPSC-derived cerebellar organoids that allows for the reproducible and large-scale production of organoids that recapitulate key features of cerebellar development.

  8. Effect Of NK-EVs And Carboplatin On Osimertinib-Resistant Lung Cancer Cells 12/18/2024

    Delve into a study that examines the possibility of the combination of NK-cell-derived EVs and CBP as a viable immunochemotherapeutic strategy for resistant cancers.

  9. Calls For Increased Education And Support For Sickle Cell Blood Therapy In US 12/13/2024

    Sickle cell patients face limited access to effective treatments. Advocacy groups are pushing for greater awareness of innovative therapies like apheresis to improve outcomes and address resource gaps.

  10. Navigating Regulatory Challenges In Oligonucleotide Therapeutics 12/12/2024

    Oligonucleotide therapies offer precise treatments for genetic disorders and chronic diseases. They face unique regulatory challenges but hold great promise, especially when combined with FDA engagement.